211 related articles for article (PubMed ID: 32841507)
1. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
2. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
Weng MY; Huang YT; Liu MF; Lu TH
Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cancer in a cohort of patients with primary Sjögren syndrome in Argentina.
Brom M; Moyano S; Gandino IJ; Scolnik M; Soriano ER
Rheumatol Int; 2019 Oct; 39(10):1697-1702. PubMed ID: 31471716
[TBL] [Abstract][Full Text] [Related]
5. Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren's syndrome measured using the Korean Health Insurance Claims Database.
Ahn JK; Hwang J; Seo GH
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):40-46. PubMed ID: 31969226
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
Liang Y; Yang Z; Qin B; Zhong R
Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
[TBL] [Abstract][Full Text] [Related]
7. The risk of cancer in patients with primary Sjögren syndrome: a single-center study from Turkey.
Aslan B; Öğüt TS; Erbasan F; Dilbil M; Çelik E; Terzioğlu ME; Yazısız V
Turk J Med Sci; 2022 Jun; 52(3):587-595. PubMed ID: 36326315
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
[TBL] [Abstract][Full Text] [Related]
9. Male patients with primary Sjögren's syndrome: A distinct clinical subgroup?
Park Y; Lee J; Park SH; Kwok SK
Int J Rheum Dis; 2020 Oct; 23(10):1388-1395. PubMed ID: 32918388
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of malignancy in patients aged over 50 with idiopathic inflammatory myositis compared to patients with osteoarthritis of the knee.
Kim H; Sung YK; Choi S; Im SG; Jung SY; Jang EJ; Yoo DH; Cho SK
Mod Rheumatol; 2020 Sep; 30(5):870-877. PubMed ID: 31442092
[No Abstract] [Full Text] [Related]
11. Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren's syndrome in Korea: A nationwide, population-based study.
Kim HJ; Kim KH; Hann HJ; Han S; Kim Y; Lee SH; Kim DS; Ahn HS
Semin Arthritis Rheum; 2017 Oct; 47(2):222-227. PubMed ID: 28729155
[TBL] [Abstract][Full Text] [Related]
12. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).
Kauppi M; Pukkala E; Isomäki H
Cancer Causes Control; 1997 Mar; 8(2):201-4. PubMed ID: 9134244
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren's syndrome: A systematic review and meta-analysis.
He C; Chen Z; Liu S; Chen H; Zhang F
Int J Rheum Dis; 2020 Aug; 23(8):1009-1018. PubMed ID: 32588976
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database.
Goulabchand R; Malafaye N; Jacot W; Witkowski Durand Viel P; Morel J; Lukas C; Rozier P; Lamure S; Noel D; Molinari N; Mura T; Guilpain P
Autoimmun Rev; 2021 Dec; 20(12):102987. PubMed ID: 34718160
[TBL] [Abstract][Full Text] [Related]
15. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
16. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
17. Autonomic dysfunction in primary Sjogren's syndrome: a prospective cohort analysis of 154 Korean patients.
Koh JH; Kwok SK; Lee J; Park SH
Korean J Intern Med; 2017 Jan; 32(1):165-173. PubMed ID: 27017389
[TBL] [Abstract][Full Text] [Related]
18. Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
Deng J; Liu M; Xiao R; Wang J; Liao X; Ye Z; Sun Z
Front Immunol; 2022; 13():904682. PubMed ID: 35844507
[TBL] [Abstract][Full Text] [Related]
19. Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort.
Zhang W; Feng S; Yan S; Zhao Y; Li M; Sun J; Zhang FC; Cui Q; Dong Y
Rheumatology (Oxford); 2010 Mar; 49(3):571-7. PubMed ID: 20040528
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of Sjogren's syndrome in systemic sclerosis: A nationwide population study.
Tseng CC; Yen JH; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Chang SJ
Autoimmunity; 2015; 48(7):438-44. PubMed ID: 25980318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
